Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06574009 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Better Options for Chronic Cancer Pain

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Site details revised at 1 of 2 sitesv10
  2. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Oct 1, 2025 to Oct 7, 2025 · Site details revised at 2 of 2 sitesv9 Show 2 more changesShow less
    • Start date changed from estimate of Oct 1, 2025 to Oct 7, 2025
    • Site details revised at 2 of 2 sites
  3. Start date: Jul 1, 2025 to Oct 1, 2025v8
  4. Start date: Apr 1, 2025 to Jul 1, 2025v7
  5. 4 versions Re-verified since Nov 27, 2024, no change to tracked fieldsv3-v6
  6. Phase: Not applicable to Phase 4v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This proposal is relevant to the 240,000 cancer survivors who continue to use opioids long after they have successfully completed treatment for cancer at the VHA, placing them at risk of opioid addiction and overdose, and other opioid-related problems. Yet, there are no programs at the VHA to help them find alternatives to opioids, nor evidence to inform the choice of interventions. This study will meet these needs by examining four interventions that are effective at reducing opioid use in patients with chronic musculoskeletal pain but have yet to be tested in cancer survivors on long term opioid therapy. The proposed work is relevant to the VHA Pain Office's mission to provide Veterans better pain management while limiting the risks of long-term opioid therapy and it aligns with VHA Research and Development's priority to examine clinical interventions for tapering opioids. Successful completion this project will keep VHA at the forefront of the battle against the opioid epidemic with a strategy that may be adapted to address the same needs in non-Veterans.
Trial Details
NCT Number NCT06574009
Lead Sponsor VA Office of Research and Development
Conditions Chronic Pain, Cancer Survivor, Opioid Dependence
Enrollment 294 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov